Falma Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 3.00 Cr
as on 17-12-2024
- Company Age 39 Year, 16 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.30 Cr
as on 17-12-2024
- Revenue -17.15%
(FY 2022)
- Profit 56.07%
(FY 2022)
- Ebitda 44.67%
(FY 2022)
- Net Worth -0.05%
(FY 2022)
- Total Assets 0.02%
(FY 2022)
About Falma Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company has closed loans amounting to ₹1.30 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kollenmareth Isaac, Prabir Sarkar, Subrata Dasgupta, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230KA1985PTC007328
- Company No.
007328
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 1985
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Falma Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kollenmareth Isaac  | Director | 21-Jun-2012 | Current |
| Prabir Sarkar | Additional Director | 05-Aug-2013 | Current |
| Subrata Dasgupta | Additional Director | 15-May-2019 | Current |
| Subhas Banerjee | Additional Director | 01-Jul-2015 | Current |
Financial Performance and Corporate Structure Insights of Falma Laboratories.
Falma Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 17.15% decrease. The company also saw a substantial improvement in profitability, with a 56.07% increase in profit. The company's net worth dipped by a decrease of 0.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Falma Laboratories?
In 2020, Falma Laboratories had a promoter holding of 67.79% and a public holding of 32.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Discovery Knowledge Systems LimitedActive 13 years 5 monthsSubrata Dasgupta and Subhas Banerjee are mutual person
Prudential Investment Ltd.Active 40 years 11 monthsSubrata Dasgupta and Subhas Banerjee are mutual person
- Prudential Stock Broking Services LtdActive 34 years 1 month
Subrata Dasgupta and Subhas Banerjee are mutual person
- Eduexel Infotainment LimitedActive 34 years 3 months
Subrata Dasgupta and Subhas Banerjee are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Karnataka State Financial Corporation Creation Date: 15 Mar 1995 | ₹4.68 M | Satisfied |
Karnataka State Finance Corporation Creation Date: 30 Apr 1994 | ₹2.30 M | Satisfied |
Karnataka State Financial Corporation Creation Date: 14 May 1988 | ₹1.15 M | Satisfied |
How Many Employees Work at Falma Laboratories?
Falma Laboratories has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Falma Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Falma Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
